Molina Healthcare, Inc. (MOH)
USD 296.59
(1.65%)
USD 296.59
(1.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.67 Billion USD | 14.19% |
| 2022 | 9.35 Billion USD | -2.39% |
| 2021 | 9.57 Billion USD | 28.82% |
| 2020 | 7.43 Billion USD | 54.05% |
| 2019 | 4.82 Billion USD | -12.35% |
| 2018 | 5.5 Billion USD | -22.81% |
| 2017 | 7.13 Billion USD | 21.57% |
| 2016 | 5.86 Billion USD | 16.92% |
| 2015 | 5.01 Billion USD | 44.77% |
| 2014 | 3.46 Billion USD | 64.3% |
| 2013 | 2.11 Billion USD | 83.08% |
| 2012 | 1.15 Billion USD | 28.47% |
| 2011 | 897.07 Million USD | 13.53% |
| 2010 | 790.15 Million USD | 12.48% |
| 2009 | 702.49 Million USD | 10.02% |
| 2008 | 638.52 Million USD | -6.21% |
| 2007 | 680.82 Million USD | 53.23% |
| 2006 | 444.3 Million USD | 71.57% |
| 2005 | 258.96 Million USD | 27.42% |
| 2004 | 203.23 Million USD | 64.88% |
| 2003 | 123.26 Million USD | 12.36% |
| 2002 | 109.69 Million USD | 29.27% |
| 2001 | 84.86 Million USD | 25.9% |
| 2000 | 67.4 Million USD | -16.77% |
| 1999 | 80.99 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 11.02 Billion USD | 3.21% |
| 2024 Q2 | 10.34 Billion USD | -6.15% |
| 2024 Q3 | 10.98 Billion USD | 6.25% |
| 2023 Q3 | 10.99 Billion USD | 9.47% |
| 2023 Q1 | 10.08 Billion USD | 7.84% |
| 2023 FY | 10.67 Billion USD | 14.19% |
| 2023 Q2 | 10.04 Billion USD | -0.43% |
| 2023 Q4 | 10.67 Billion USD | -2.86% |
| 2022 Q3 | 9.75 Billion USD | 0.1% |
| 2022 FY | 9.35 Billion USD | -2.39% |
| 2022 Q1 | 9.56 Billion USD | -0.14% |
| 2022 Q2 | 9.74 Billion USD | 1.84% |
| 2022 Q4 | 9.35 Billion USD | -4.12% |
| 2021 Q1 | 7.78 Billion USD | 4.71% |
| 2021 FY | 9.57 Billion USD | 28.82% |
| 2021 Q4 | 9.57 Billion USD | 12.5% |
| 2021 Q3 | 8.51 Billion USD | 4.35% |
| 2021 Q2 | 8.16 Billion USD | 4.8% |
| 2020 Q3 | 5.68 Billion USD | -3.4% |
| 2020 Q1 | 5.48 Billion USD | 13.57% |
| 2020 FY | 7.43 Billion USD | 54.05% |
| 2020 Q4 | 7.43 Billion USD | 30.92% |
| 2020 Q2 | 5.88 Billion USD | 7.26% |
| 2019 FY | 4.82 Billion USD | -12.35% |
| 2019 Q4 | 4.82 Billion USD | -0.88% |
| 2019 Q1 | 5.74 Billion USD | 4.3% |
| 2019 Q3 | 4.87 Billion USD | -1.7% |
| 2019 Q2 | 4.95 Billion USD | -13.75% |
| 2018 Q3 | 6.49 Billion USD | -8.66% |
| 2018 FY | 5.5 Billion USD | -22.81% |
| 2018 Q1 | 7.58 Billion USD | 6.25% |
| 2018 Q2 | 7.1 Billion USD | -6.27% |
| 2018 Q4 | 5.5 Billion USD | -15.15% |
| 2017 Q1 | 6.31 Billion USD | 7.55% |
| 2017 FY | 7.13 Billion USD | 21.57% |
| 2017 Q4 | 7.13 Billion USD | -5.2% |
| 2017 Q3 | 7.52 Billion USD | 6.56% |
| 2017 Q2 | 7.06 Billion USD | 11.9% |
| 2016 FY | 5.86 Billion USD | 16.92% |
| 2016 Q1 | 5.59 Billion USD | 11.44% |
| 2016 Q2 | 5.56 Billion USD | -0.57% |
| 2016 Q3 | 5.87 Billion USD | 5.72% |
| 2016 Q4 | 5.86 Billion USD | -0.19% |
| 2015 Q1 | 4.12 Billion USD | 19.07% |
| 2015 FY | 5.01 Billion USD | 44.77% |
| 2015 Q3 | 4.39 Billion USD | 2.9% |
| 2015 Q2 | 4.27 Billion USD | 3.52% |
| 2015 Q4 | 5.01 Billion USD | 14.15% |
| 2014 Q2 | 2.53 Billion USD | 5.81% |
| 2014 Q3 | 3.09 Billion USD | 21.97% |
| 2014 Q4 | 3.46 Billion USD | 12.13% |
| 2014 Q1 | 2.39 Billion USD | 13.54% |
| 2014 FY | 3.46 Billion USD | 64.3% |
| 2013 FY | 2.11 Billion USD | 83.08% |
| 2013 Q4 | 2.11 Billion USD | 3.83% |
| 2013 Q3 | 2.03 Billion USD | 19.29% |
| 2013 Q2 | 1.7 Billion USD | -1.18% |
| 2013 Q1 | 1.72 Billion USD | 49.58% |
| 2012 Q3 | 1.15 Billion USD | -1.66% |
| 2012 Q2 | 1.17 Billion USD | 21.43% |
| 2012 Q1 | 964.69 Million USD | 7.54% |
| 2012 FY | 1.15 Billion USD | 28.47% |
| 2012 Q4 | 1.15 Billion USD | 0.04% |
| 2011 FY | 897.07 Million USD | 13.53% |
| 2011 Q4 | 897.07 Million USD | 7.24% |
| 2011 Q3 | 836.48 Million USD | 0.23% |
| 2011 Q1 | 842.64 Million USD | 6.64% |
| 2011 Q2 | 834.56 Million USD | -0.96% |
| 2010 FY | 790.15 Million USD | 12.48% |
| 2010 Q1 | 637.12 Million USD | -9.31% |
| 2010 Q3 | 733.69 Million USD | -7.54% |
| 2010 Q4 | 790.15 Million USD | 7.7% |
| 2010 Q2 | 793.55 Million USD | 24.55% |
| 2009 Q1 | 678.25 Million USD | 6.22% |
| 2009 Q2 | 668.98 Million USD | -1.37% |
| 2009 FY | 702.49 Million USD | 10.02% |
| 2009 Q3 | 679.23 Million USD | 1.53% |
| 2009 Q4 | 702.49 Million USD | 3.43% |
| 2008 Q4 | 638.52 Million USD | -1.73% |
| 2008 FY | 638.52 Million USD | -6.21% |
| 2008 Q1 | 642.6 Million USD | -5.61% |
| 2008 Q2 | 679.29 Million USD | 5.71% |
| 2008 Q3 | 649.77 Million USD | -4.35% |
| 2007 FY | 680.82 Million USD | 53.23% |
| 2007 Q3 | 477.57 Million USD | 0.74% |
| 2007 Q4 | 680.82 Million USD | 42.56% |
| 2007 Q2 | 474.07 Million USD | 6.55% |
| 2007 Q1 | 444.92 Million USD | 0.14% |
| 2006 FY | 444.3 Million USD | 71.57% |
| 2006 Q3 | 370.98 Million USD | 4.48% |
| 2006 Q2 | 355.06 Million USD | 25.36% |
| 2006 Q1 | 283.23 Million USD | 9.37% |
| 2006 Q4 | 444.3 Million USD | 19.77% |
| 2005 FY | 258.96 Million USD | 27.42% |
| 2005 Q1 | 196.38 Million USD | -3.37% |
| 2005 Q2 | 211.51 Million USD | 7.71% |
| 2005 Q4 | 258.96 Million USD | 7.52% |
| 2005 Q3 | 240.84 Million USD | 13.87% |
| 2004 Q2 | 121.25 Million USD | 2.26% |
| 2004 FY | 203.23 Million USD | 64.88% |
| 2004 Q4 | 203.23 Million USD | 15.57% |
| 2004 Q3 | 175.85 Million USD | 45.03% |
| 2004 Q1 | 118.57 Million USD | -3.8% |
| 2003 Q2 | 151.91 Million USD | 17.53% |
| 2003 FY | 123.26 Million USD | 12.36% |
| 2003 Q4 | 123.26 Million USD | 9.13% |
| 2003 Q3 | 112.94 Million USD | -25.65% |
| 2003 Q1 | 129.25 Million USD | 0.0% |
| 2002 FY | 109.69 Million USD | 29.27% |
| 2001 FY | 84.86 Million USD | 25.9% |
| 2000 FY | 67.4 Million USD | -16.77% |
| 1999 FY | 80.99 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cigna Corporation | 101.57 Billion USD | 89.489% |
| Centene Corporation | 58.68 Billion USD | 81.806% |
| CVS Health Corporation | 173.09 Billion USD | 93.832% |
| Elevance Health Inc. | 69.52 Billion USD | 84.642% |
| Humana Inc. | 10.21 Billion USD | -4.543% |
| Oscar Health, Inc. | 2.55 Billion USD | -318.022% |
| UnitedHealth Group Incorporated | 179.49 Billion USD | 94.052% |